Nivolumab
CA045-011
Phase 1 mab completed
Quick answer
Nivolumab for Renal Cell Carcinoma is a Phase 1 program (mab) at NEKTAR THERAPEUTICS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEKTAR THERAPEUTICS
- Indication
- Renal Cell Carcinoma
- Phase
- Phase 1
- Modality
- mab
- Status
- completed